GTBP

Conviction 27HealthcareScan · Tue, Sep 8, 2026

GTBP$5.21+2061.83%

ResistanceSupportVol 14

Vol MA14 438.47K

Jun 9Jun 26Jul 16Aug 3Aug 20Sep 8

GT Biopharma, Inc.PHARMACEUTICAL PREPARATIONSwww.gtbiopharma.com ↗

Price5.21

Change+2061.83%

Gap+2368.88%

Rel volume0.33×

Avg volume465.92K

Avg $ vol170.59K

SMA 200.5342

SMA 500.4374

SMA 2000.5028

Price vs 50+1091.20%

Price vs 200+936.21%

MA stackmixed

50/200 cross—

Supertrendup · 3.71

RSI (14)98

MACD hist0.31

MACD crossbull · 0d

Stoch %K / %D87 / 36

ADX (14)35

+DI / −DI95 / 2

RSI divergence—

MACD divergenceBullish

ATR %+8.24%

ADR %7.18%

52w high5.21

52w low0.2410

From 52w high+0.00%

Above 52w low+2061.83%

New 52w highYes

SqueezeFired

Bollinger width803.24%

%B1.59

Donchian pos87.08%

Donchian high5.95

Donchian low0.2221

AVWAP (52w high)5.39

vs AVWAP high-3.40%

AVWAP (52w low)0.8564

vs AVWAP low+508.33%

OBV trendDown

Chaikin MF (20)-0.31

Today vs 20d0.33×

Avg vol (14d)438.47K

Avg vol (20d)465.92K

Avg $ vol (20d)170.59K

Market cap235.02M

RS 3m (vs SPY)-49.20%

RS 6m (vs SPY)-63.19%

RS line new highNo

Trend template4/8

Technical rank99.7

1 week+1721.68%

1 month+1527.62%

3 months+1125.31%

6 months+1149.40%

1 year+451.32%

YTD+537.62%

P/E-8.29

P/B65.85

P/S—

P/FCF-18.20

EPS-6.68

Div yield0.10%

ROE-794.45%

ROA-349.79%

Debt/Eq—

Current2.61

EV/EBITDA—

Gross margin—

Net margin—

Rev growth—

EPS growth-115.42%

Price target—

Target upside—

Analyst rating—

Institutional—

Ent. value230.06M

Revenue0

Net income-4.52M

Gross profit0

Free cash flow-12.91M

IndustryPHARMACEUTICAL PREPARATIONS

ExchangeNasdaq

Shares out36.06M

Employees1

ListedThu, Feb 11, 2021

Free float29.5M

Float %93.5%

Short interest4.06M

Days to cover9.3d

Short volume32.1%

Squeeze score53 / 100

Next earnings—

EPS forecast—

Last EPS vs est—

Last surprise—

Setup gradeD

Conviction27 / 100

Pattern quality—

Tech rank99.7 / 100

Group rank—

Status laneNo active setup

Setup direction—

Pattern family

Resistance0.3347

Support0.2752

Days since event—

Candle confirm—

News sentiment—

Financials as of Tue, Jun 30, 2026 · quarterly.

Congress activity

Disclosed STOCK Act trades in GTBP

All disclosures →

No recent disclosed trades by Congress in GTBP. STOCK Act filings can lag the trade by up to 45 days.

Insider activity

SEC Form 4 transactions in GTBP

No recent insider (Form 4) filings in GTBP. Insiders must file within two business days of a trade.

SEC filings

EDGAR filings in GTBP · 6 recent

EDGAR →

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.

Start free — 14-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.